Abstract

BackgroundSystemic Lupus Erythematosus (SLE) is a complex disease with limited treatment options. Understand the extent of disease burden among key subsets of patients (such as those experiencing flares) could help...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
#894 Real-world treatment patterns in recurrent or advanced endometrial cancer patients who initiated second-line systemic therapy in 5 European countries: a retrospective chart review study
Christian Marth ... Nicola Miles
International Journal of Gynecologic Cancer | VOL. 33
Christian Marth, et. al.Christian Marth ... Nicola Miles
01 Sep 2023
AB0790 Clinical characteristics, treatment patterns and disease control among patients with systemic lupus erythematosus receiving steroid-containing standard care regimens in germany, france and spain.
S Narayanan ... Y Lu
Annals of the Rheumatic Diseases | VOL. 72
S Narayanan, et. al.S Narayanan ... Y Lu
01 Jun 2013
#888 Real-world treatment patterns in recurrent or advanced endometrial cancer patients who initiated first-line systemic therapy in 5 European countries: a retrospective chart review study
Vimalanand S Prabhu ... Christian Marth
International Journal of Gynecologic Cancer | VOL. 33
Vimalanand S Prabhu, et. al.Vimalanand S Prabhu ... Christian Marth
01 Sep 2023
MO926: Development and Implementation of an Electronic Patient-Reported Outcome System to Support Health-Related Quality of Life Management in a Large, European Dialysis Network
Abraham Rincon Bello ... Alessandro Pizzo
Nephrology Dialysis Transplantation | VOL. 37
Abraham Rincon Bello, et. al.Abraham Rincon Bello ... Alessandro Pizzo
03 May 2022
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers